**Question:** All of the following are true about therapy for tuberculosis, except -

A. Drug-resistant tuberculosis requires a longer treatment duration
B. Treatment for smear-negative pulmonary tuberculosis involves isoniazid and rifampicin
C. Steroids are commonly used in tuberculosis treatment to reduce inflammation
D. The use of fluoroquinolones in tuberculosis treatment is controversial

**Correct Answer:** **D. The use of fluoroquinolones in tuberculosis treatment is controversial.**

**Core Concept:**

Tuberculosis (TB) is an infectious disease primarily caused by the bacterium Mycobacterium tuberculosis. Standard treatment for TB involves a combination of antibiotics to ensure effective killing of the bacterium and prevent drug resistance. Treatment for smear-negative pulmonary tuberculosis, particularly, involves isoniazid and rifampicin, which target the mycobacterial cell wall synthesis and DNA replication, respectively. Drug-resistant TB, on the other hand, requires a longer treatment duration, usually extending from the standard 6 months to 18-24 months, depending on the type and extent of drug resistance.

**Why the Correct Answer is Right:**

Fluoroquinolones are a class of antibiotics that are often used in the treatment of TB due to their bactericidal activity against M. tuberculosis. However, the use of fluoroquinolones in TB treatment is controversial due to potential adverse effects and drug interactions.

**Why Each Wrong Option is Incorrect:**

A. Treatment duration for drug-resistant TB may be longer, but it is not typically described as "controversial." Controversy exists more around the use of fluoroquinolones due to their potential side effects and interactions.

B. Steroids are not commonly used in the initial treatment of pulmonary TB, as they primarily target inflammation and are not directly bactericidal against M. tuberculosis. Instead, antibiotics are the primary agents used to kill the bacteria.

C. Steroids are used in some cases of TB to reduce inflammation and improve patient outcomes, particularly in cases of severe disease or complications (e.g., TB meningitis). However, it is not controversial regarding their use, unlike fluoroquinolones.

**Clinical Pearl:**

In TB treatment, the selection of antibiotics and adjuvant therapy is crucial for optimal patient outcomes. While steroids may be beneficial in specific cases, controversy revolves around the use of fluoroquinolones due to their potential side effects and drug interactions. Consider a personalized treatment plan for each patient, taking into account their general health condition, drug allergies, and potential interactions with other medications.